HR 3821 · 119th Congress · Health

ADINA Act

Introduced 2025-06-06· Sponsored by Rep. Morrison, Kelly [D-MN-3]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2025-06-06)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 3821 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 3821 To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 6, 2025 Ms. Morrison (for herself, Mr. Lawler, Ms. Matsui, Mr. Cline, Mr. Fitzpatrick, and Mr. Bacon) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress asse…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (17)

10 Democrats7 Republicans